HENRIK CLAUSEN

Full professor


email: hclau@sund.ku.dk
phone: (+45) 20 14 55 37 / (+45) 35 33 54 85



Current Position:

- 2005-present: Professor, Institute of Cellular and Molecular Medicine, Copenhagen, Denmark

 

 Education and Training

- 1981: DDS (Doctor of Dental Surgery), School of Dentistry, Faculty of Health Sciences, Copenhagen, Denmark

- 1990: Dr.odont (D.Sc., Doctorate in Dentistry - equivalent to PhD), School of Dentistry, Faculty of Health Sciences, Copenhagen, Denmark

 

Professional and Academic Background:

- 1981-1982: Intern, Danish Navy, general practitioner

- 1982-1986: Research Fellow, School of Dentistry, Faculty of Health Sciences, Copenhagen

- 1983-1986: Visiting Research Fellow, Fred Hutchinson Cancer Research Center, Program of Biochemical Oncology, and University of Washington, Seattle, USA

- 1986-1990: Research Assistant Professor, University of Washington, Seattle, USA

- 1986-1990: Head, Department of Immunogenetics, The Biomembrane Institute, Seattle, USA

- 1990-1991: Associate Professor (lektor), Department of Oral Diagnostics, School of Dentistry, Faculty of Health Sciences, Copenhagen

- 1991-2004: Senior Associate Professor (docent), Department of Oral Diagnostics, School of Dentistry, Faculty of Health Sciences, Copenhagen

- 2000-2005: Visiting Lecturer in Pathology, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, USA

 

Consulting and International Roles:

- 1994-1998: Member, Scientific Advisory Board, Aptein Inc., USA

- 1998-present: Member, General Scientific Advisory Board, Neose Inc., USA

- 2000-present: Consultant, ZymeQuest Inc., USA

- 2001-present: Member, GlycoAdvance Scientific Advisory Board, Neose Inc., USA

- 2001-present: National Representative, IGO (International Glycoconjugate Organization)

- 2002: Consultant, Millennium Pharmaceuticals, USA

 

Scientific Skills:

- Glycosylation and glycobiology - internationally recognized expertise

- Glycosyltransferases - enzymes involved in glycan synthesis

- Cancer-Associated Mucins

- Carbohydrates and immunity - role of sugars in immune response

- Blood group antigens - blood group antigens and their glycosylation

- Protein glycosylation and its role in pathology

- Membrane biology and glycoconjugates

 

Methodological Expertise:

- Biochemistry of complex carbohydrates

- Glycosyltransferase enzymology

- Molecular immunology

- Biotechnological approaches for glycosylation manipulation

- Structural studies of glycans

 

Scientific Leadership:

- National Representative, IGO (International Glycoconjugate Organization)

- Member of Scientific Advisory Boards of US biotechnology companies

- Organizer of international symposia and congresses in glycobiology

 

 Research Activities

 

Main Research Areas:

1. Cancer Glycobiology:

   - Cancer-associated mucins and their aberrant glycosylation

   - Role of glycosylation in tumor progression

   - Potential therapeutic targets based on tumor glycans

   - Glycan biomarkers for cancer diagnosis and prognosis

 

2. Glycosyltransferases:

   - Structural and functional characterization of glycosyltransferases

   - Regulation of glycosyltransferase expression

   - Substrate specificity and catalytic mechanisms

   - Biotechnological applications of glycosyltransferases

 

3. Carbohydrates and Immunity:

   - Carbohydrate antigens and immune response

   - Role of glycans in immune recognition

   - Immunoglobulin glycosylation

   - Glycans as modulators of immune response

 

4. Blood Group Antigens:

   - Biosynthesis of blood group antigens

   - Glycosyltransferases involved in blood group determination

   - Clinical and transfusion implications

   - Genetic polymorphisms and phenotypic variants

 

International Conference Organization (selection):

- Benzon Symposia (Copenhagen, 1993, 2007)

- Nordic Glycobiology Symposia (Copenhagen, multiple editions 1992-2004)

- International Cancer-Associated Mucin Workshop (1994-2009, multiple locations)

- International Workshop on Mucin Glycosylation (Copenhagen, 1997)

- XIII International Symposium on Glycoconjugates (Zurich, 1997)

- Symposium on Carbohydrate and Immunity (Lesbos, 1997, 1999)

- International Workshop on Glycosylation and Immunity (Greece, 2001)

- Glycosyltransferases symposia (Toronto 2000, Stockholm 2002, Le Touquet 2004, Tsukuba 2006, Atlanta 2008)

- Gordon Conference on Glycobiology (Ventura, Los Angeles, 2001)

 

International Experiences:

- 1983-1986: Visiting Research Fellow, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, USA

- 1986-1990: Research Assistant Professor, University of Washington, Seattle, USA

- 1986-1990: Head, Department of Immunogenetics, The Biomembrane Institute, Seattle, USA

- 2000-2005: Visiting Lecturer in Pathology, BIDMC, Harvard Medical School, USA

 

International Collaborations:

- Scientific consulting for US biotechnology companies (Aptein, Neose, ZymeQuest, Millennium Pharmaceuticals)

- National Representative for IGO (International Glycoconjugate Organization)

- Organization of international congresses in Europe, USA, Asia

 

Biotechnological Applications:

- Consulting for development of glycosylation-based technologies (Neose Inc., ZymeQuest Inc.)

- Contributions to development of therapeutic approaches based on glycosylation manipulation

- Advisory roles for pharmaceutical applications (Millennium Pharmaceuticals)

 

Translational Research:

- Identification of glycan biomarkers for cancer diagnosis

- Development of therapeutic strategies based on targeting tumor mucins

- Diagnostic applications of glycosylation patterns

 

Scientific Output:

- Extensive scientific production in glycobiology, with publications in high-impact international journals

 

Awards and Honours:

- Benzow Prize (1994)

- Thureus Prize (1998)

- Mizutani Prize (1999) - prestigious international prize in glycobiology

- Carlsberg Biotechnology Prize (2008)

 

Editorial Activities:

- Member, Editorial Board, Glycoconjugate Journal (1995-present)

- Member, Editorial Board, Journal of Biological Chemistry (2004-present)

 

Scientific Impact:

- Fundamental contributions to understanding glycosylation in cancer

- Internationally recognized leader in glycosyltransferases field

- Pioneer in cancer-associated mucin studies

- Contributions to defining role of carbohydrates in immunity

 

Scientific Organization:

- Organizer of over 20 international symposia and workshops in glycobiology

- Session chair at numerous international congresses

- Leadership in International Glycoconjugate Organization


© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma